Clinical trial
Virological and Clinical Anti-HBV Efficacy of Tenofovir and Emtricitabine in Antiretroviral Naïve Patients With HIV/HBV co-Infection
NCT00127959 is registered in ClinicalTrials.gov with International Antiviral Therapy Evaluation Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Virological and Clinical Anti-HBV Efficacy of Tenofovir and Emtricitabine in Antiretroviral Naïve Patients With HIV/HBV co-Infection
- Lead sponsor
- International Antiviral Therapy Evaluation Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2004
- Completion date
- August 31, 2006
- Enrollment
- 24
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.